# Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil

Study · id `cardio:ct-nct02729740` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02729740](<https://clinicaltrials.gov/study/NCT02729740>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02729740

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 995 participants.

## Technical summary

Registry record NCT02729740. Allocation not applicable; no masking; primary purpose treatment. Start 2016-06-03 (actual); primary completion 2019-12-27 (actual). Results posted on 2021-03-01.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 995 participants (enrolled count; ClinicalTrials.gov record NCT02729740, source copy `cardio:ctgov-nct02729740-2021-03-01`, retrieved 2026-11-18)
- Started: 2016-06-03 (actual) (ClinicalTrials.gov record NCT02729740, source copy `cardio:ctgov-nct02729740-2021-03-01`, retrieved 2026-11-18)
- Primary completion: 2019-12-27 (actual) (ClinicalTrials.gov record NCT02729740, source copy `cardio:ctgov-nct02729740-2021-03-01`, retrieved 2026-11-18)
- Completion: 2019-12-27 (actual) (ClinicalTrials.gov record NCT02729740, source copy `cardio:ctgov-nct02729740-2021-03-01`, retrieved 2026-11-18)
- Results first posted: 2021-03-01 (ClinicalTrials.gov record NCT02729740, source copy `cardio:ctgov-nct02729740-2021-03-01`, retrieved 2026-11-18)
- Countries: United States; Canada (ClinicalTrials.gov record NCT02729740, source copy `cardio:ctgov-nct02729740-2021-03-01`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02729740-2021-03-01`, retrieved 2026-11-18)

## The registry's words

- Brief title: Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil
- Acronym: SMART
- Condition: Intracranial Aneurysm
- Intervention (Device): Penumbra Smart Coil
- Intervention (Device): Penumbra Coil 400TM (PC400), Penumbra Occlusion DeviceTM(POD)
- Lead sponsor: Penumbra Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as the lead sponsor: Penumbra Inc. (`cardio:org-penumbra-inc`)

## Provenance

Content hash: aa3e4e2d94e5e6ca29b612d8d1121644c60d09efb53e96329428cc3407f30348
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
